Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1633 1651 1699
This examiner grants 56% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17624744 | METHOD FOR PRODUCING CULTURE MEDIUM COMPOSITION FOR SUSPENSION CULTURING ADHERENT CELLS | Final Rejection | NISSAN CHEMICAL CORPORATION |
| 18682987 | GENE THERAPY PRODUCTS FACILITATING BYSTANDER EFFECTS AND METHODS USING THE SAME | Non-Final OA | The University of North Carolina at Chapel Hill |
| 18636969 | CELL CULTIVATION METHOD, CELL SUPPORT COMPOSITE PRODUCTION METHOD, CULTIVATED CELLS, AND CELL SUPPORT COMPOSITE | Non-Final OA | NIKKISO CO., LTD. |
| 18636926 | CELL CULTIVATION METHOD, CELL SUPPORT COMPOSITE PRODUCTION METHOD, CULTIVATED CELLS, AND CELL SUPPORT COMPOSITE | Non-Final OA | NIKKISO CO., LTD. |
| 18543705 | Regeneration of a Functional Pulmonary Vascular Bed | Non-Final OA | The General Hospital Corporation |
| 18052600 | RESPIRATORY SYNCTIAL VIRUS RNA VACCINE | Non-Final OA | SANOFI |
| 18304694 | METHODS OF CONTROLLING RED BLOOD CELL PRODUCTION | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18609070 | Use of Short Chain Fatty Acids in Cancer Prevention | Non-Final OA | Temple University-Of The Commonwealth System of Higher Education |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy